Patients with B cell chronic lymphocytic leukaemia have an expanded population of CD4+perforin expressing T cells enriched for human cytomegalovirus specificity and an effector-memory phenotype

被引:9
|
作者
Walton, James A. [1 ]
Lydyard, Peter M. [1 ]
Nathwani, Amit [2 ]
Emery, Vincent [3 ]
Akbar, Arne [4 ]
Glennie, Martin J. [5 ]
Porakishvili, Nino [1 ]
机构
[1] Univ Westminster, Sch Life Sci, London W1W 6UW, England
[2] UCL, Sch Med, Dept Haematol, London W1N 8AA, England
[3] UCL, Sch Med, Dept Virol, London W1N 8AA, England
[4] UCL, Sch Med, Dept Immunol, London W1N 8AA, England
[5] Univ Southampton, Tenovus Res Lab, Canc Sci Div, Southampton, Hants, England
基金
美国国家卫生研究院;
关键词
chronic lymphocytic leukaemia; cytomegalovirus; cytotoxicity; cytotoxic CD4 cells; HIGH-LEVEL REPLICATION; CD4(+); VIRUS; RESPONSES; HETEROGENEITY; EXPANSION; THERAPY; PROTECT; VIREMIA; CLONES;
D O I
10.1111/j.1365-2141.2009.07964.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P>We have previously shown an expansion of cytotoxic antigen-experienced CD4+T cells (CTLs) that express perforin (PF) in the peripheral blood of patients with B cell chronic lymphocytic leukaemia (B-CLL). Increased frequencies of CD4+CTLs have since been attributed to chronic viral infections, particularly, human cytomegalovirus (HCMV). The present study examined the involvement of CD4+CTLs in responses to HCMV in B-CLL, and characterized their differentiation. We studied 36 HCMV seropositive (SP) and seronegative B-CLL patients and 20 healthy age-matched individuals. The HCMV reactivity of CD4+PF+ and CD4+PF- cells was determined by interferon-gamma expression, and expression of CD45RA and CCR7 was assessed by flow cytometry. Fluorescence in-situ hybridization was used to measure relative telomere lengths. CD4+PF+T cell expansion in B-CLL patients and controls was strongly associated with HCMV seropositivity. CD4+PF+ compared to CD4+PF- cells from SP B-CLL patients elicited major histocompatibility complex (MHC) class II-restricted responses to HCMV. CD4+PF+T cells from patients and controls were enriched with highly differentiated T-effector/memory (CCR7-) and revertant (CCR7-CD45RA+) phenotype. CD4+PF+T cells from B-CLL patients had shorter telomeres than CD4+PF-T cells, indicating an extensive replicative history. We conclude that persistent exposure to HCMV antigens in SP B-CLL patients leads to an expansion of the circulating MHC class II-restricted CD4+PF+T cell population with effector/memory phenotype.
引用
收藏
页码:274 / 284
页数:11
相关论文
共 36 条
  • [1] Perforin expressing CD4+T cells respond to CMV antigens in CMV seropositive patients with B cell chronic lymphocytic leukaemia (B-CLL).
    Walton, J
    Lawson, K
    Manoussaka, MS
    Nathwani, A
    Emory, V
    Lydyard, PM
    Porakishvili, N
    BLOOD, 2004, 104 (11) : 280B - 280B
  • [2] Autologous cytomegalovirus-specific T cells as effector cells in immunotherapy of B cell chronic lymphocytic leukaemia
    Kater, AP
    Remmerswaal, EBM
    Nolte, MA
    Eldering, E
    van Oers, MHJ
    van Lier, RAW
    BRITISH JOURNAL OF HAEMATOLOGY, 2004, 126 (04) : 512 - 516
  • [3] Phenotypic and functional characterisation of perforin expressing blood CD4+cells in patients with B chronic lymphocytic leukaemia (B-CLL).
    Porakishvili, N
    Roschupkina, T
    Kalber, T
    Jewell, AP
    Patterson, K
    Yong, KL
    Lydyard, PM
    BLOOD, 2000, 96 (11) : 162A - 162A
  • [4] CD4+PF+ T cells with regulatory phenotype in B cell chronic lymphocytic leukaemia (B-CLL).
    Porakishvili, N
    Jewell, AP
    Kwee, Y
    Akbar, A
    Lydyard, PM
    BLOOD, 2002, 100 (11) : 356B - 356B
  • [5] Expansion of CD4+ T cells with a cytotoxic phenotype in patients with B-chronic lymphocytic leukaemia (B-CLL)
    Porakishvili, N
    Roschupkina, T
    Kalber, T
    Jewell, AP
    Patterson, K
    Yong, K
    Lydyard, PM
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2001, 126 (01): : 29 - 36
  • [6] The number of cytomegalovirus-specific CD4+ T cells is markedly expanded in patients with B-cell chronic lymphocytic leukemia and determines the total CD4+ T-cell repertoire
    Pourgheysari, Batoul
    Bruton, Rachel
    Parry, Helen
    Billingham, Lucinda
    Fegan, Chris
    Murray, Jim
    Moss, Paul
    BLOOD, 2010, 116 (16) : 2968 - 2974
  • [7] Cytotoxic CD4+ T cells in patients with B cell chronic lymphocytic leukemia kill via a perforin-mediated pathway
    Porakishvili, N
    Kardava, L
    Jewell, AP
    Yong, K
    Glennie, MJ
    Akbar, A
    Lydyard, PM
    HAEMATOLOGICA, 2004, 89 (04) : 435 - 443
  • [8] CD20+ T cells have a predominantly Tc1 effector memory phenotype and are expanded in the ascites of patients with ovarian cancer
    de Bruyn, Marco
    Wiersma, Valerie R.
    Wouters, Maartje C. A.
    Samplonius, Douwe F.
    Klip, Harry G.
    Helfrich, Wijnand
    Nijman, Hans W.
    Eggleton, Paul
    Bremer, Edwin
    ONCOIMMUNOLOGY, 2015, 4 (04):
  • [9] CD28nullCD4+ T cells:: an effector memory T cell population in patients with rheumatoid arthritis
    Fasth, AER
    Cao, D
    van Vollenhoven, R
    Trollmo, C
    Malmström, V
    ARTHRITIS RESEARCH & THERAPY, 2004, 6 (Suppl 1) : S13 - S13
  • [10] CD28nullCD4+ T cells: an effector memory T cell population in patients with rheumatoid arthritis
    AER Fasth
    D Cao
    R van Vollenhoven
    C Trollmo
    V Malmström
    Arthritis Res Ther, 6